Publications by authors named "Signe Svindland"

Claim this Profile
A
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Signe C Svindland, Gabriel K Pedersen, Rishi D Pathirana, Geir Bredholt, Jane K Nøstbakken

Influenza Other Respir Viruses· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.
Signe C Svindland, Åsne Jul-Larsen, Rishi Pathirana, Solveig Andersen, Abdullah Madhun

Influenza Other Respir Viruses· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP.
Gabriel Kristian Pedersen, Thomas Ebensen, Ingrid Hjetland Gjeraker, Signe Svindland, Geir Bredholt

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial.
Rebecca J Cox, Gabriel Pedersen, Abdullah S Madhun, Signe Svindland, Marianne Sævik

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.
Abdullah S Madhun, Per Espen Akselsen, Haakon Sjursen, Gabriel Pedersen, Signe Svindland

Vaccine· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis